Home/CPT codes/11980

CPT 11980Surgery

Implant hormone pellet(s)

CPT code 11980 is used when a healthcare provider inserts hormone pellets under the skin, typically for hormone replacement therapy. The small pellets release hormones slowly over several months.

Showing rates for

National Average

Base Medicare rate

$91.54

This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.

RVU breakdown

Work RVU

1.1

PE RVU (NF)

1.58

MP RVU

0.15

Total RVU

2.83

Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High

NCCI bundling edits

Loading bundling edits…

Billing tips

Verify LCD coverage policy before scheduling: Many Medicare Administrative Contractors (MACs) consider hormone pellet therapy investigational or not medically necessary, leading to automatic denials. Obtain an Advance Beneficiary Notice (ABN) when Medicare coverage is uncertain.
Impact: Can prevent $91.54 write-off per procedure and ensure patient financial responsibility is established; reduces bad debt by 100% when patient signs ABN
Bill in non-facility settings when possible to capture the full $91.54 rate versus $53.37 facility rate, a difference of $38.17 per procedure.
Impact: Increases revenue by 71.5% compared to facility billing; annual impact of $3,817 per 100 procedures performed in office setting
Document the exact number of pellets implanted, hormone type, dosage per pellet, total dosage, and specific medical necessity including failed alternative therapies. Many payers require trial of conventional HRT before approving pellet therapy.
Impact: Reduces denial rate by approximately 40-60%; claims with complete documentation showing failed alternatives have 3x higher approval rate
Use diagnosis codes that support medical necessity: E89.40 (asymptomatic postprocedural ovarian failure), N95.1 (menopausal symptoms), E29.1 (testicular hypofunction), rather than vague symptom codes. Link to laboratory values showing hormone deficiency.
Impact: Improves first-pass approval rate by 35-50%; reduces appeals work and accelerates payment by 15-30 days on average
Bill the pellets separately using HCPCS code S0189 (testosterone pellet) or appropriate J-codes when applicable, as the pellet cost is not included in the 11980 procedure reimbursement.
Impact: Recovers $150-$400+ in supply costs per procedure that would otherwise be absorbed; critical for maintaining positive margin

Live Field Datano reports yet

Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.

Working with CPT 11980?

Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.

Help build the field knowledge

MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.

Related actions

Common denials

Investigational/experimental procedure - Many commercial payers and some Medicare MACs consider bioidentical hormone pellet therapy unproven or not meeting coverage criteria for hormone replacement.

How to appeal: Submit peer-reviewed literature supporting efficacy, clinical practice guidelines from endocrine societies, documentation of failed conventional therapies, and specific patient-centered outcomes. Request independent medical review citing FDA approval of hormone pellet products and established clinical use since 1930s. Include manufacturer product insert showing FDA approval status.

Medical necessity not established - Denials citing lack of documented hormone deficiency via laboratory testing or insufficient trial of alternative hormone delivery methods.

How to appeal: Provide lab results showing hormone deficiency (specific values and reference ranges), document patient-specific contraindications or failures with pills, patches, or creams (dates, dosages, side effects), and include clinical notes detailing symptom severity and functional impact. Demonstrate pellet therapy is appropriate based on patient adherence issues or therapeutic failure.

Cosmetic or wellness service exclusion - Payers may classify hormone optimization for anti-aging or quality of life as non-covered cosmetic/wellness service.

How to appeal: Emphasize therapeutic medical diagnoses (hypogonadism, surgical menopause, documented endocrine disorder) rather than wellness goals. Submit clinical documentation showing disease-state treatment, not enhancement. Reference Medicare Benefit Policy Manual or payer policy language distinguishing treatment of disease from cosmetic care. Avoid anti-aging or wellness terminology in documentation.

Bundling with E/M service - Denial of separately billed E/M code on same date of service, claiming pre-procedure assessment is included in the procedure code.

How to appeal: Document that the E/M service addressed separate medical issues beyond the pellet implant procedure, was a significant separately identifiable service, and meets modifier 25 criteria. Provide detailed E/M documentation showing history, exam, and MDM unrelated to the implant or performed for initial comprehensive evaluation prior to decision for pellet therapy. Clearly distinguish the E/M work from the typical pre-procedure assessment.

Frequently asked questions

What is the Medicare reimbursement rate for CPT code 11980 in 2025?

The 2025 Medicare national average reimbursement for CPT 11980 is $91.54 in non-facility settings and $53.37 in facility settings. The non-facility rate is 71.5% higher because it includes practice expense for equipment, supplies, and staff that facilities provide separately. Actual payment varies by geographic location based on local cost adjustments.

Does Medicare cover hormone pellet implantation (CPT 11980)?

Medicare coverage for 11980 varies by jurisdiction and medical necessity. Some Medicare Administrative Contractors cover pellet therapy for FDA-approved indications like hypogonadism when medical necessity is established through lab values and failed alternative therapies. However, many MACs have Local Coverage Determinations listing it as investigational or not reasonable and necessary. Always verify LCD policies for your specific MAC and obtain an ABN when coverage is uncertain.

Can I bill an E/M code with CPT 11980 on the same day?

Yes, you can bill an E/M service with 11980 on the same day using modifier 25, but only when the E/M represents a significant, separately identifiable service beyond the typical pre-procedure assessment. The E/M must involve evaluation of other conditions or be a comprehensive initial consultation where the decision for pellet therapy is made. Documentation must clearly distinguish the E/M work from routine pre-procedure assessment to avoid denials.

How many RVUs is CPT code 11980 worth?

CPT 11980 has a total of 2.83 RVUs for 2025, consisting of 1.1 work RVUs, 1.58 non-facility practice expense RVUs (0.4 for facility), and 0.15 malpractice RVUs. These RVUs multiplied by the 2025 conversion factor of $32.3465 determine the Medicare payment rates of $91.54 non-facility and $53.37 facility.

Are hormone pellets covered by commercial insurance for CPT 11980?

Commercial insurance coverage varies significantly by carrier and plan. Many commercial payers restrict coverage, classify pellet therapy as investigational, or exclude it as a wellness service. Some plans cover it only for specific FDA-approved indications with documented hormone deficiency and failed conventional therapies. Always verify benefits before scheduling, obtain prior authorization when required, and consider cash-pay options with patient financial agreements for high-risk denials.

What diagnosis codes support medical necessity for CPT 11980?

Appropriate diagnosis codes include E29.1 (testicular hypofunction), E89.40 (asymptomatic postprocedural ovarian failure), E89.41 (symptomatic postprocedural ovarian failure), N95.1 (menopausal and female climacteric states), Z90.710 (acquired absence of both cervix and uterus for surgical menopause), and E28.310 (premature menopause). Link codes to laboratory documentation showing hormone deficiency. Avoid vague symptom codes without documented endocrine deficiency.

What is the global period for CPT code 11980?

CPT 11980 has a 10-day global period. This means routine post-operative care for 10 days following the procedure is included in the procedure payment and should not be billed separately. Only complications or unrelated E/M services can be billed during this period, typically requiring modifier 24 for unrelated E/M services or modifier 25 if performed on the same day as the procedure for a separate issue.